Company Filing History:
Years Active: 2025
Title: Huiru Lv: Innovator in Pharmaceutical Development
Introduction
Huiru Lv is a prominent inventor based in Beijing, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. Her work focuses on enhancing drug delivery systems to improve patient outcomes.
Latest Patents
Huiru Lv holds a patent for an oral solid tablet comprising Bruton's Tyrosine Kinase inhibitor and its preparation method. The patent describes an oral solid tablet that includes (S)-7-[4-(1-acryloylpiperidine)]-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide. This formulation exhibits excellent drug release characteristics, ensuring easy administration and quick, efficient release. The preparation process is straightforward, requiring no special equipment, which contributes to formulation stability and facilitates transportation and storage. This innovation is particularly suitable for large-scale production.
Career Highlights
Huiru Lv is currently associated with BeiGene Switzerland GmbH, where she continues to advance her research and development efforts. Her work has positioned her as a key player in the pharmaceutical industry, focusing on innovative solutions that address critical healthcare needs.
Collaborations
Huiru has collaborated with notable colleagues, including Gang Qiu and Yiwei Shen, to further enhance her research initiatives. These collaborations have fostered a dynamic environment for innovation and development within her field.
Conclusion
Huiru Lv's contributions to pharmaceutical innovation, particularly through her patented oral solid tablet, highlight her role as a leading inventor in the industry. Her work not only improves drug delivery systems but also paves the way for future advancements in pharmaceutical formulations.